0001209191-16-130107.txt : 20160629
0001209191-16-130107.hdr.sgml : 20160629
20160629172735
ACCESSION NUMBER: 0001209191-16-130107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160627
FILED AS OF DATE: 20160629
DATE AS OF CHANGE: 20160629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 807-6600
MAIL ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc
DATE OF NAME CHANGE: 20090130
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lim Richard J.
CENTRAL INDEX KEY: 0001623720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 161739786
MAIL ADDRESS:
STREET 1: 185 DARTMOUTH STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-27
0
0001178711
Paratek Pharmaceuticals, Inc.
PRTK
0001623720
Lim Richard J.
C/O PARATEK PHARMACUTICALS, INC.
75 KNEELAND STREET
BOSTON
MA
02111
1
0
0
0
Common Stock
2016-06-27
4
P
0
384615
13.00
A
779802
I
By Omega Fund IV, L.P.
Common Stock
2016-06-27
4
P
0
76923
13.00
A
1187365
I
By Omega Fund III, L.P.
These securities are held in the name of Omega Fund IV, L.P. ("Omega IV"). The Reporting Person is a director of Omega Fund IV GP Manager, Ltd., the general partner of Omega Fund IV GP, L.P., which is the general partner of Omega IV, and has shared voting and investment power over, and a proportionate pecuniary interest in, the shares held by Omega IV. The Reporting Person disclaims beneficial ownership of the securities held by Omega IV except to the extent of his proportionate pecuniary interest therein.
These securities are held in the name of Omega Fund III, LP. ("Omega III"). Omega Fund III GP, L.P. ("Omega III GP LP") is the general partner of Omega III. Omega Fund III G.P., Ltd. ("Omega III GP") is the general partner of Omega III GP LP. Clessidra, LLC ("Clessidra") is the sole shareholder of Omega III GP. Omega III, Omega III GP LP, Omega III GP, Clessidra, Danish BV and Danish BV GP are collectively referred to as the "Omega Funds". As a result of an understanding relating to the Omega Funds, the Reporting Person may have an indirect pecuniary interest in the securities held by Omega III. The Reporting Person disclaims beneficial ownership of the securities held by Omega III except to the extent of his pecuniary interest therein.
/s/ Richard J. Lim
2016-06-29